GSK_ Annual_Report_2021-22

NOTES TO THE FINANCIAL STATEMENTS for the year ended March 31, 2022 191 Note 21 : Changes In Inventories Of Finished Goods, Work-In-Progress and traded goods ( ` in lakhs) Year ended March 31, 2022 Year ended March 31, 2021 Opening stock Work-in-progress 23.98 - Finished goods 11,65.82 - Traded goods - - Less: Closing stock Work-in-progress 14.76 23.98 Finished goods 10,00.33 11,65.82 Traded goods - - 1,74.71 (11,89.80) Note 22 : Finance costs ( ` in lakhs) Year ended March 31, 2022 Year ended March 31, 2021 Interest cost on financial liabilities measured at amortized cost 45.43 - 45.43 - Note 23 : Other expenses ( ` in lakhs) Year ended March 31, 2022 Year ended March 31, 2021 Manufacturing charges 13,03.40 3,94.87 Rates and taxes 9.55 4.51 Statutory audit fees 5.59 3.45 In other capacity in respect of : Tax audit fees 1.05 0.70 Reimbursement of expenses - 0.30 Reimbursement of expenses to GlaxoSmithKline Pharmaceuticals Limited 61.46 25.33 Repairs and Maintenance - 2.63 Tax and consulting fees 17.31 5.53 Security guard services 24.76 24.43 Third party warehousing 4.57 5.58 Miscellaneous expenses 4.37 3.36 Provision for bad and doubtful loans and advances - - 14,32.06 4,70.69 Note 24 : EARNINGS PER SHARE ( ` in lakhs) Year ended March 31, 2022 Year ended March 31, 2021 Earnings per share Earnings per share is calculated by dividing the profit attributable to the equity shareholders by the weighted average number of equity shares outstanding during the year. The numbers used in calculating basic and diluted earnings per equity share are as stated below: Profit /(loss) after taxation ( ` Lakhs) 4,19.35 57.98 Weighted average number of shares (Nos) 960,000 960,000 Earnings per share (Basic and Diluted) - ` 43.68 6.04 Face value per share - ` 10.00 10.00 Note 25 : Tax expense (a) Amounts recognised in profit and loss ( ` in lakhs) For the year ended March 31, 2022 For the year ended March 31, 2021 Current income tax 31.88 - Deferred tax Decrease (increase) in deferred tax assets 109.25 18.24 (Decrease) increase in deferred tax liabilities - - Adjustment to deferred tax attributable to change in Income Tax rates - - Deferred tax expense 109.25 18.24 Tax expense for the year 141.13 18.24